No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease

Neuroscience Letters

Volumn 341, Issue 3, 2003, Pages 229-232

  Monastero, Roberto ^a   Cefalù, Angelo B ^b   Camarda, Cecilia ^a   Buglino, Carmela M ^b   Mannino, Marina ^a   Barbagallo, Carlo M ^b   Lopez, Gianluca ^a   Camarda, Lawrence K C ^a   Travali, Salvatore ^c   Camarda, Rosolino ^a   Averna, Maurizio R ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Alzheimer's Disease; Apolipoprotein E; Case control study; Nitric oxide synthase 3 (NOS3); Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA ISOLATION; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; POPULATION GENETICS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0344406946     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00210-6     Document Type: Article

References (20)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
2. Alvarez R., Alvarez V., Lahoz C.H., Martinez C., Pena J., Sanchez J.M., Guisasola L.M., Salas-Puig J., Moris G., Vidal J.A., Ribacoba R., Menes B.B., Uria D., Coto E. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 67:1999;733-736.
3. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
4. Crawford F., Freeman M., Abdullah L., Schinka J., Gold M., Duara R., Mullan M. No association between the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States. Ann. Neurol. 47:2000;687.
5. Dahiyat M., Cumming A., Harrington C., Wischik C., Xuereb J., Corrigan F., Breen G., Shaw D., St Clair D. Association between Alzheimer's disease and the NOS3 gene. Ann. Neurol. 46:1999;664-667.
6. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
7. Fratiglioni L., De Ronchi D., Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 15:1999;365-375.
8. Higuchi S., Ohta S., Matsushita S., Matsui T., Yuzuriha T., Urakami K., Arai H. NOS3 polymorphism not associated with Alzheimer's disease in Japanese. Ann. Neurol. 48:2000;685.
9. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid. Res. 31:1990;545-548.
10. Kunugi H., Akahane A., Ueki A., Otsuka M., Isse K., Hirasawa H., Kato N., Nabika T., Kobayashi S., Nanko S. No evidence for an association between the Glu298Asp polymorphism of the NOS3 gene and Alzheimer's disease. J. Neural. Transm. 107:2000;1081-1084.
11. Law A., Gauthier S., Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Brain Res. Rev. 35:2001;73-96.
12. McGeer P.L., McGeer E.G. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch. Neurol. 58:2001;1790-1792.
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
14. Prince J.A., Feuk L., Sawyer S.L., Gottfries J., Ricksten A., Nagga K., Bogdanovic N., Blennow K., Brookes A.J. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur. J. Hum. Genet. 9:2001;437-444.
15. Rosenberg R.N. The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture. Neurology. 54:2000;2045-2054.
16. Singleton A.B., Gibson A.M., McKeith I.G., Ballard C.G., Edwardson J.A., Morris C.M. Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neurosci. Lett. 303:2001;33-36.
17. Tedde A., Nacmias B., Cellini E., Bagnoli S., Sorbi S. Lack of association between NOS3 polymorphism and Italian sporadic and familial Alzheimer's disease. J. Neurol. 249:2002;110-111.
18. Wilson R.I., Yanovsky J., Godecke A., Stevens D.R., Schrader J., Haas H.L. Endothelial nitric oxide synthase and LTP. Nature. 386:1997;338.
19. Xu W., Liu L., Emson P., Harrington C.R., McKeith I.G., Perry R.H., Morris C.M., Charles I.G. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. NeuroReport. 11:2000;297-299.
20. Zandi P.P., Breitner J.C. Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence. Neurobiol. Aging. 22:2001;811-817.